Vyome Holdings, Inc. (HIND) stock news · rev $319.7K
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
This HIND news page leads with what Vyome Holdings, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for HIND yet. We will not pad this page with generic market recap.
Latest reported HIND revenue for 2025-12-31 was $319.7K. Net income was -$10.3M. Revenue was down 96.3% from 2023-12-31 to 2025-12-31. HIND currently screens at market cap $16.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the HIND stock page; for the tape open the quote page.
HIND stock news FAQ
What are HIND's latest revenue and net income?
Latest cached Vyome Holdings, Inc. (HIND) revenue for Dec 31, 2025 was $319.7K. Net income was -$10.3M. Statements: https://lician.com/financials/hind
How did HIND revenue change from the prior cached period?
Cached Vyome Holdings, Inc. (HIND) revenue was down 96.3% from $8.7M (Dec 31, 2023) to $319.7K (Dec 31, 2025). Statements: https://lician.com/financials/hind
What is HIND's market cap?
Vyome Holdings, Inc. (HIND) market cap is $16.1M on the latest cached fundamentals snapshot.
What kind of company is HIND?
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
Where is HIND stock news listed?
Cached stock news for Vyome Holdings, Inc. (HIND) is listed at https://lician.com/news/hind. Filings: https://lician.com/sec/hind
Not investment advice.